📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington's disease (Enroll-HD). (2020)

First Author: Harris KL

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2019-322038

PubMed Identifier: 32229581

Publication URI: http://europepmc.org/abstract/MED/32229581

Type: Journal Article/Review

Volume: 91

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 6

ISSN: 0022-3050